82.46
2.65%
+2.13
After Hours:
82.46
Encompass Health Corp stock is currently priced at $82.46, with a 24-hour trading volume of 635.81K.
It has seen a +2.65% increased in the last 24 hours and a +7.78% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $80.22 pivot point. If it approaches the $82.99 resistance level, significant changes may occur.
Encompass Health Corp Stock (EHC) Financials Data
Encompass Health Corp (EHC) Revenue 2024
EHC reported a revenue (TTM) of $4.80 billion for the quarter ending December 31, 2023, a +10.41% rise year-over-year.
Encompass Health Corp (EHC) Net Income 2024
EHC net income (TTM) was $352.00 million for the quarter ending December 31, 2023, a +29.89% increase year-over-year.
Encompass Health Corp (EHC) Cash Flow 2024
EHC recorded a free cash flow (TTM) of $267.70 million for the quarter ending December 31, 2023, a +119.97% increase year-over-year.
Encompass Health Corp (EHC) Earnings per Share 2024
EHC earnings per share (TTM) was $3.47 for the quarter ending December 31, 2023, a +28.52% growth year-over-year.
Encompass Health Corp Stock (EHC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
COLTHARP DOUGLAS E | EVP & Chief Financial Officer |
Nov 13 '23 |
Option Exercise |
26.55 |
16,623 |
441,341 |
127,508 |
COLTHARP DOUGLAS E | EVP & Chief Financial Officer |
Nov 13 '23 |
Sale |
63.39 |
11,215 |
710,919 |
116,293 |
Charbonneau Elissa Joy | Chief Medical Officer |
Aug 17 '23 |
Sale |
69.58 |
8,294 |
577,097 |
23,081 |
Tarr Mark J | President & CEO |
Aug 16 '23 |
Option Exercise |
26.55 |
25,330 |
672,512 |
522,735 |
Tarr Mark J | President & CEO |
Aug 16 '23 |
Sale |
71.06 |
25,330 |
1,799,950 |
497,405 |
Encompass Health Corp Stock (EHC) Latest News
Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?
Zacks Investment Research
Insights Into Encompass Health (EHC) Q1: Wall Street Projections for Key Metrics
Zacks Investment Research
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
Zacks Investment Research
Elevance Health (ELV), CD&R to Unveil Primary Care Offering
Zacks Investment Research
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Zacks Investment Research
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
About Encompass Health Corp
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of November 29, 2018, Encompass Health Corporation operated 130 hospitals, and 273 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Cap:
|
Volume (24h):